BOSTON — Amid emerging reports of vaping-related illnesses nationwide, Cannabis Control Commission will require more disclosure of additives included in marijuana products sold in Massachusetts.

“Its intent is to disclose to patients or consumers what is actually in the product that they may be procuring,” said commission Executive Director Shawn Collins.

Nationally, as of Sept. 6, the Centers for Disease Control and Prevention identified 450 possible cases of severe lung disease tied to the use of e-cigarettes or vaping products. Six people have died. No cases have been confirmed in Massachusetts.

No product has been conclusively linked to the disease. But New York officials have said they are looking at the use of vitamin E acetate, an oily chemical sometimes used as an additive in vape cartridges.

New York investigators have subpoenaed records from Mass Terpenes of Amherst, Massachusetts, which sells vitamin E acetate oil.

The Cannabis Control Commission, which is voting on changes to its regulations Thursday, voted unanimously to require marijuana product manufacturers to include on a product’s list of ingredients all additives, including specific terpenes and thickening agents, that are used in the product. Current rules only require the ingredient list to include information about the cannabinoid profile of marijuana and its THC content.

Commissioner Jennifer Flanagan said customers today are worried about additives, given the safety concerns in the vaping industry.

“This gives us one layer of protection to tell people what’s in the products,” Flanagan said. “It gives consumers an added layer of information to understand what they’re ingesting.”

Commission Chairman Steven Hoffman said the change is a continuation of the commission’s public awareness campaign, which is meant to encourage people to consume marijuana responsibly. “One of the ways we can help people consume responsibly is give them more information,” Hoffman said.

Collins described the requirement as a “first step” to address public health concerns, by improving transparency about what is in products. Collins said the commission is also collaborating with labs to better understand their testing capabilities related to inactive ingredients. The commission will work with other state agencies, such as the Department of Public Health, to determine if additional steps should be taken.

The Massachusetts Department of Public Health on Wednesday issued a mandate requiring health care providers to immediately report all vaping-associated pulmonary diseases to the department.